Hinge Health Inc. Class A Common Stock vs KeyCorp — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.52 (market cap $8.47B), while KeyCorp trades at $19.83 (market cap $21.12B). The key difference: KeyCorp is far larger — about 2.5× Hinge Health Inc. Class A Common Stock's market cap, and KeyCorp pays a 4.14% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and KeyCorp for 66 Days on average.
| HNGE | KEY | |
|---|---|---|
Market Cap | $8.47B | $21.12B |
Volume | 1,624,526 | 21,616,814 |
Sector | Health | Financials |
52-Week High | $105.14 | $23.99 |
52-Week Low | $31.17 | $16.78 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $8.09B | $34.30B |
Dividend Yield | — | 4.14% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
KeyCorp (KEY) trades at $19.91, down 0.9% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company shows strong profitability with a net income margin of 26.72% and has beaten EPS estimates for three consecutive quarters. Recent corporate actions include a dividend payment scheduled for September 2026 and key executive appointments in wealth and retail banking.
The outlook is supported by analyst consensus with a $25.00 price target and 60.79% buy ratings, though risks include volatile cash flows and competitive pressures. Revenue growth momentum and aggressive share buybacks provide upside potential, but investors face headwinds from interest rate sensitivity and economic uncertainty.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →